This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Eubacteriales: NCBI 186802, [order]

Back to details

| Clostridiales| Clostridiales Prevot 1953| Eubacteriales| Eubacteriales Buchanan 1917 (Approved Lists 1980) emend. Gerritsen et al. 2014

  1. Short-Chain Fatty Acid Production:

    • Some bacteria within the order Eubacteriales are involved in the fermentation of dietary fibers in the colon, producing short-chain fatty acids (SCFAs) as byproducts. SCFAs, such as butyrate, propionate, and acetate, have various health benefits. They serve as an energy source for colonocytes, contribute to gut barrier integrity, and have anti-inflammatory effects.
  2. Metabolism:

    • Eubacteriales includes bacteria with diverse metabolic functions. Some species may be involved in the metabolism of complex carbohydrates, contributing to the breakdown of dietary fibers and the production of beneficial metabolites.
  3. Gut Microbiota Composition:

    • Members of Eubacteriales are part of the complex ecosystem of the human gut microbiota. Changes in the relative abundance of Eubacteriales have been observed in various health conditions, including inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and metabolic disorders.
  4. Potential Probiotic Effects:

    • Some bacteria within the order Eubacteriales may have probiotic potential, contributing to the balance and diversity of the gut microbiota. Probiotics are beneficial microorganisms that can confer health benefits to the host.
  5. Anti-inflammatory Properties:

    • Certain bacteria within Eubacteriales may produce metabolites with anti-inflammatory properties, influencing the immune response in the gut. This can be important for maintaining gut health and preventing excessive inflammation.

Other Sources for more information:

Legend

Eubacteriales impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.460352510213851930.5315372943878174MicromonosporalesParent Taxa
0.378756433725357060.5320457816123962RhodospirillalesParent Taxa
0.369909465312957760.49461135268211365MyxococcalesParent Taxa
0.35648506879806520.548761248588562SpirochaetalesParent Taxa
0.345939606428146360.5227813720703125GemmatimonadalesParent Taxa
0.34580335021018980.49466225504875183NostocalesParent Taxa
0.277816653251647950.5268155932426453ErysipelotrichalesParent Taxa

Other bacteria of the same rank impacting Eubacteriales

R2SlopeTax NameParent Chart
0.45563590526580810.7355180382728577SpirochaetalesParent Taxa
0.44848173856735230.7659785151481628RhodospirillalesParent Taxa
0.27901029586791990.5287423729896545ErysipelotrichalesParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]